History | Advocacy services for adults with health and social care needs | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Declaration of interests

Register of interests (PDF 420 KB)

Published:

09 November 2022

Guidance published

Consultation comments and responses (PDF 1.56 MB)

Published:

09 November 2022
Equality impact assessment 4 (PDF 179 KB)

Published:

09 November 2022
Supporting documentation - Acknowledgements (PDF 188 KB)

Published:

09 November 2022
Committee member list (PDF 130 KB)

Published:

17 November 2022

Stakeholder list updated

Stakeholder list (PDF 189 KB)

Published:

04 November 2022

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 717 KB)

Published:

07 June 2022
Evidence review A (PDF 725 KB)

Published:

07 June 2022
Evidence review B (PDF 978 KB)

Published:

07 June 2022
Evidence review C (PDF 792 KB)

Published:

07 June 2022
Evidence review D (PDF 870 KB)

Published:

07 June 2022
Evidence review E (PDF 706 KB)

Published:

07 June 2022
Evidence review F (PDF 724 KB)

Published:

07 June 2022
Evidence review G (PDF 741 KB)

Published:

07 June 2022
Evidence review H (PDF 661 KB)

Published:

07 June 2022
Evidence review I (PDF 660 KB)

Published:

07 June 2022
Evidence review J (PDF 606 KB)

Published:

07 June 2022
Evidence review K (PDF 1.09 MB)

Published:

07 June 2022
Supporting documentation - Methods (PDF 320 KB)

Published:

07 June 2022
Supporting documentation - Acknowledgements (PDF 186 KB)

Published:

07 June 2022
Equality impact assessment 3 (PDF 294 KB)

Published:

07 June 2022
Comments form (MSWord 41 KB)

Published:

07 June 2022

Committee meetings

Committee meeting
Minutes 1 (PDF 244 KB)

Published:

06 May 2021
Minutes 2 (PDF 228 KB)

Published:

27 May 2021
Minutes 3 (PDF 233 KB)

Published:

08 July 2021
Minutes 4 (PDF 238 KB)

Published:

29 July 2021
Minutes 5 (2 day meeting) (PDF 252 KB)

Published:

17 August 2021
Minutes 6 (PDF 228 KB)

Published:

07 September 2021
Minutes 7 (2 day meeting) (PDF 258 KB)

Published:

04 October 2021
Minutes 8 (2 day meeting) (PDF 252 KB)

Published:

08 November 2021
Minutes 9 (2 day meeting) (PDF 257 KB)

Published:

29 November 2021
Minutes 10 (PDF 224 KB)

Published:

10 January 2022
Minutes 11 (2 day meeting) (PDF 255 KB)

Published:

26 January 2022
Minutes 12 (2 day meeting) (PDF 291 KB)

Published:

08 August 2022

Call for evidence

Call for evidence
Confidentiality form (MSWord 70 KB)

Published:

15 March 2021
Call for evidence response form (MSWord 40 KB)

Published:

15 March 2021

Scope published

Consultation comments and responses (PDF 938 KB)

Published:

11 March 2021
Equality impact assessment 2 (PDF 208 KB)

Published:

11 March 2021
Final scope (PDF 187 KB)

Published:

26 August 2021

Draft scope consultation

Draft scope consultation
Draft scope (PDF 183 KB)

Published:

21 December 2020
Equality impact assessment 1 (PDF 155 KB)

Published:

21 December 2020
Comments form (MSWord 37 KB)

Published:

21 December 2020